Literature DB >> 25482564

Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors.

Shong Lau1, Daniella Rylander Ottosson1, Johan Jakobsson1, Malin Parmar2.   

Abstract

Recent findings show that human fibroblasts can be directly programmed into functional neurons without passing via a proliferative stem cell intermediate. These findings open up the possibility of generating subtype-specific neurons of human origin for therapeutic use from fetal cell, from patients themselves, or from matched donors. In this study, we present an improved system for direct neural conversion of human fibroblasts. The neural reprogramming genes are regulated by the neuron-specific microRNA, miR-124, such that each cell turns off expression of the reprogramming genes once the cell has reached a stable neuronal fate. The regulated system can be combined with integrase-deficient vectors, providing a nonintegrative and self-regulated conversion system that rids problems associated with the integration of viral transgenes into the host genome. These modifications make the system suitable for clinical use and therefore represent a major step forward in the development of induced neurons for cell therapy.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25482564     DOI: 10.1016/j.celrep.2014.11.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  20 in total

Review 1.  New approaches for direct conversion of patient fibroblasts into neural cells.

Authors:  Suhasni Gopalakrishnan; Pooja Hor; Justin K Ichida
Journal:  Brain Res       Date:  2015-10-16       Impact factor: 3.252

Review 2.  High-Diversity Mouse Populations for Complex Traits.

Authors:  Michael C Saul; Vivek M Philip; Laura G Reinholdt; Elissa J Chesler
Journal:  Trends Genet       Date:  2019-05-24       Impact factor: 11.639

Review 3.  MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases.

Authors:  Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-06-29       Impact factor: 5.590

Review 4.  MicroRNA-regulated viral vectors for gene therapy.

Authors:  Anja Geisler; Henry Fechner
Journal:  World J Exp Med       Date:  2016-05-20

Review 5.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

6.  Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin.

Authors:  Zixiao Shi; Juan Zhang; Shuangquan Chen; Yanxin Li; Xuepei Lei; Huimin Qiao; Qianwen Zhu; Baoyang Hu; Qi Zhou; Jianwei Jiao
Journal:  J Biol Chem       Date:  2016-05-02       Impact factor: 5.157

7.  Direct In Vitro Reprogramming of Astrocytes into Induced Neurons.

Authors:  Nesrin Sharif; Filippo Calzolari; Benedikt Berninger
Journal:  Methods Mol Biol       Date:  2021

8.  Direct reprogramming of somatic cells into neural stem cells or neurons for neurological disorders.

Authors:  Shaoping Hou; Paul Lu
Journal:  Neural Regen Res       Date:  2016-01       Impact factor: 5.135

9.  Direct Conversion of Human Fibroblasts to Induced Neurons.

Authors:  Lucia Zhou-Yang; Sophie Eichhorner; Lukas Karbacher; Lena Böhnke; Larissa Traxler; Jerome Mertens
Journal:  Methods Mol Biol       Date:  2021

Review 10.  Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application.

Authors:  Lakshmy Vasan; Eunjee Park; Luke Ajay David; Taylor Fleming; Carol Schuurmans
Journal:  Front Cell Dev Biol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.